Welcome to LookChem.com Sign In|Join Free
  • or
Phenol, 3-(ethylmethylamino)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

50564-17-5

Post Buying Request

50564-17-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

50564-17-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 50564-17-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,0,5,6 and 4 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 50564-17:
(7*5)+(6*0)+(5*5)+(4*6)+(3*4)+(2*1)+(1*7)=105
105 % 10 = 5
So 50564-17-5 is a valid CAS Registry Number.

50564-17-5Relevant academic research and scientific papers

Facile synthesis of [11C]edrophonium and its analogues as new potential PET imaging agents for heart acetylcholinesterase

Zheng, Qi-Huang,Liu, Xuan,Fei, Xiangshu,Wang, Ji-Quan,Mock, Bruce H.,Glick-Wilson, Barbara E.,Sullivan, Michael L.,Hutchins, Gary D.

, p. 1787 - 1790 (2003)

[11C]Edrophonium and its analogues have been synthesized for evaluation as new potential positron emission tomography (PET) imaging agents for heart acetylcholinesterase. The tracers were prepared by N-[11C]methylation of precursors

OXAZINE-BASED FLUOROPHORE COMPOUNDS FOR NERVE-SPECIFIC IMAGING

-

Page/Page column 45-46, (2021/07/31)

This invention concerns novel oxazine-based fluorophore compounds useful in invivo nerve imaging, as well as compositions comprising them and methods for their use.

ACYL SULFONAMIDES FOR TREATING CANCER

-

Page/Page column 279, (2020/11/03)

The present invention provides acyl sulfonamide compounds of general formula (I): in which X, R1, R2, R3, R4, R5, R6, Ra and Rb are as described and defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients as well as methods of treating and/or prophylaxing diseases, particularly cancer, more particularly cancer in which KAT6A and/or KAT6B is focally amplified, said method comprising administering an effective amount of at least one compound of formula (I) to a subject in need thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 50564-17-5